DMC Biotechnologies
Boulder, CO · Biotechnology · 51 employees
DMC is a U.S. biomanufacturer seeking to transform how the world makes chemicals. The company leverages precision fermentation and synthetic biology to decarbonize chemicals, deliver more sustainable and natural food ingredients and supplements, and improve the security of global supply chains. It’s platform technology, Dynamic Metabolic Control™, simplifies biology, and enables predictable, robus
Funding history
- Funding Round — $1.4M — Dec 2025
- Funding Round — $905K — Dec 2025
- Funding Round — $4.8M — Apr 2025
- Series pre-seed — $67K — Aug 2022
- Funding Round — $33.8M — Dec 2021
Recent signals
- Dec 30, 2025: Raised $1.4M
- Dec 30, 2025: Raised $905K
- Apr 23, 2025: Raised $4.8M
- Aug 24, 2022: Raised $67K in Series pre-seed
- Dec 10, 2021: Raised $33.8M
- Jan 28, 2021: Raised $22K
- Jun 27, 2019: Raised $4.6M
- Mar 15, 2019: Raised $2.5M
See plans & pricing → Track DMC Biotechnologies’s funding, hiring, and signals — with verified contacts — on Fundz.